文献速递瓣膜外科

Trifecta与Mosaic Ultra主动脉位生物瓣的前瞻性随机比较:更低跨瓣压差与更少患者-人工瓣不匹配

Trifecta has lower gradient and less prosthesis-patient mismatch than Mosaic Ultra in the aortic position: A prospective randomized study.
PubMed 文献 · J Thorac Cardiovasc Surg · 2018-11-17

结果显示相同瓣环尺寸下Trifecta跨瓣压差更低,严重患者-人工瓣不匹配在Mosaic组为28%、Trifecta组为3%。

要点

  • 相同瓣环尺寸下Trifecta跨瓣压差低于Mosaic Ultra。
  • 严重患者-人工瓣不匹配Mosaic组28%、Trifecta组3%。
  • 用统一Hegar sizer测瓣环可避免厂商标称尺寸偏倚。

核心结论

  • 相同瓣环尺寸下,Trifecta较Mosaic Ultra跨瓣压差更低且严重患者-人工瓣不匹配更少。

研究设计与样本

  • 瓣环经Hegar sizer统一测量真实尺寸后,按随机方案植入最大可能型号,术后6个月行超声心动图评估。

主要发现

  • 两组基线参数可比。
  • 相同瓣环尺寸下Trifecta组跨瓣压差低于Mosaic Ultra组。
  • 严重患者-人工瓣不匹配在Mosaic组占28%,在Trifecta组占3%。

关键数值与推荐

  • 严重患者-人工瓣不匹配:Mosaic组28%,Trifecta组3%。

临床怎么用

  • 小至中等瓣环主动脉瓣置换选瓣时,可优先考虑跨瓣压差更低、严重不匹配更少的Trifecta。
  • 术中应以Hegar sizer实测瓣环而非厂商标称尺寸来选择最大可植入型号。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: When aortic valve replacement is needed, a biological valve is usually implanted in patients older than age 60 to 65 years. A large valvular opening area is important to avoid prosthesis-patient mismatch and facilitate reverse left ventricular remodeling. The Trifecta biological valve (St Jude Medical, St Paul, Minn) is, because of its design, believed to reduce transvalvular gradient compared with other biological valves, especially in smaller annuli. Several retrospective studies have compared transvalvular gradients of implanted valves prostheses using the respective manufacturers given size and not the actual annulus size measured by a metric sizer. This makes comparison of the hemodynamic properties of different valve brands and sizes difficult. We therefore performed a prospective randomized study, using the same metric sizer to measure annulus size, and compared hemodynamic profiles of the Trifecta to our standard Mosaic Ultra biological valve (Medtronic, Minneapolis, Minn). METHODS: Ninety elective patients with small to medium annulus diameter undergoing aortic valve replacement were randomized to either Trifecta or Mosaic Ultra. After native valve removal and decalcification, a Hegar-sizer was used to measure true annulus size. Then the largest possible valve of either brand was implanted according to the randomization protocol. Echocardiography was performed 6 months postoperatively. RESULTS: Baseline parameters of the 2 cohorts were comparable. There were lower transvalvular gradients in the Trifecta compared with the Mosaic Ultra group for the given annulus sizes. Severe prosthesis-patient mismatch was present in 28% of patients in the Mosaic group and 3% of patients in the Trifecta group. CONCLUSIONS: Trifecta showed lower transvalvular gradients and less severe prosthesis-patient mismatch compared with Mosaic Ultra for the given annulus sizes. ClinicalTrials.gov Protocol ID: 2011/2596/REK.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Braathen B, Husebye T, Lunde IG, et al. Trifecta has lower gradient and less prosthesis-patient mismatch than Mosaic Ultra in the aortic position: A prospective randomized study. J Thorac Cardiovasc Surg. 2018. PMID: 30635187. doi:10.1016/j.jtcvs.2018.11.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。